When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?
Fuccio C, Musto A, Cambioli S, Castellucci P, Pantaleo MA, Nanni C, Montini GC, Campana D, Tomassetti P, Bellan E, Massaro A, Grassetto G, Rubello D, Fanti S.
Fuccio C, et al.
Clin Nucl Med. 2011 Dec;36(12):1109-11. doi: 10.1097/RLU.0b013e31823361f7.
Clin Nucl Med. 2011.
PMID: 22064082
No abstract available.